Pengaruh Derajat Keparahan Penyakit (Skor APACHE II) terhadap Utilisasi Sumber Daya (Skor TISS-28) dan Biaya Perawatan Pasien di ICU
Abstract
ICU merupakan unit perawatan di rumah sakit yang membutuhkan biaya tinggi. Oleh karena itu, penting untuk mengevaluasi faktor-faktor yang mempengaruhi utilisasi sumber daya biaya perawatan pasien ICU. Salah satu faktor yang dapat mempengaruhi utilisasi sumber daya dan biaya perawatan ICU adalah keparahan penyakit. Penelitian ini menggunakan desain analitik observasional dengan desain kohort prospektif Subjek penelitian ini adalah pasien ICU RSUP Dr. Hasan Sadikin Bandung yang dirawat pada bulan Maret–Mei 2023. Derajat keparahan penyakit dinilai dengan skor APACHE II, sementara utilisasi sumber daya ICU dinilai dengan skor TISS-28. Uji Pearson Product Moment digunakan untuk mendapatkan nilai koefisien korelasi (r) dan koefisien determinasi (r2) skor APACHE II terhadap skor TISS-28 dan biaya perawatan pasien ICU. Sebanyak 113 pasien ICU disertakan sebagai subjek penelitian. Rata-rata skor TISS-28 harian 25,6 dan biaya perawatan harian pasien ICU Rp6.657.925,00. Dari analisis skor APACHE II terhadap skor TISS-28 harian didapatkan nilai r=0,538; r2=0,289; p ≤0,001. Sedangkan dari analisis skor APACHE II dan biaya perawatan harian pasien ICU didapatkan r=0,502;r2=0,253; p≤0,001. Derajat keparahan berdasarkan skor APACHE II berpengaruh terhadap skor TISS-28 dan biaya perawatan pasien di ICU dengan korelasi positif. Hasil studi ini diharapkan dapat membantu meningkatkan efektivitas dan efisiensi perawatan pasien di ICU.
Keywords
Full Text:
PDFReferences
- Halpern NA, Goldman DA, Tan KS, Pastores SM. Trends in critical care beds and use among population groups and medicare and medicaid beneficiaries in the United States: 2000-2010. Crit Care Med. 2016;44(8):1490–9.
- Lindemark F, Haaland ØA, Kvåle R, Flaatten H, Norheim OF, Johansson KA. Costs and expected gain in lifetime health from intensive care versus general ward care of 30,712 individual patients: a distribution-weighted cost-effectiveness analysis. Crit Care. 2017;21(1):220.
- Van Wagenberg L, Van Wagenberg L, Beurskens CJP, Stegeman I, Stegeman I, Stegeman I, dkk. Program on high value cost-conscious education in intensive care: educational program on prediction of outcome and cost awareness on Intensive Care admission. BMC Med Educ. 2020;20(1):186.
- Aung YN, Nur AM, Ismail A, Aljunid SM. Determining the cost and length of stay at intensive care units and the factors Influencing them in a teaching hospital in Malaysia. Value Health Reg Issues. 2020;21:149–56.
- Mun E, Ceria-Ulep C, Umbarger L, Nakatsuka C. Trend of decreased length of stay in the intensive care unit (ICU) and in the hospital with palliative care integration into the ICU. Perm J. 2016;20(4):16–36.
- Wang Z wen, Zheng J, You L ming, Wang Y xiu, Gao M rong, Guan X dong. Evaluation of the simplified therapeutic intervention scoring system: Chinese version. Intensive Crit Care Nurs. 2018;45:85–90.
- Karabatsou D, Tsironi M, Tsigou E, Boutzouka E, Katsoulas T, Baltopoulos G. Variable cost of ICU care, a micro-costing analysis. Intensive Crit Care Nurs. 2016;35:66–73.
- Chin-Yee N, D’Egidio G, Thavorn K, Heyland D, Kyeremanteng K. Cost analysis of the very elderly admitted to intensive care units. Crit Care. 2017;21(1):109.
- Ifatun BN, Raharjo BB. Determinan Selisih Biaya Riil dan Tarif INA CBG’s pada Pasien Jantung Koroner. Higea Journal of Public Health Research and Development [Internet]. 2021; 5(1):13–23.
- Purba AKR, Mariana N, Aliska G, Wijaya SH, Wulandari RR, Hadi U, dkk. The burden and costs of sepsis and reimbursement of its treatment in a developing country: An observational study on focal infections in Indonesia. International Journal of Infectious Diseases. 2020;96:211–8.
- Boucher PE, Taplin J, Clement F. The cost of ARDS: a systematic review. Chest. 2022.161(3):684–96.
- Bice T, Cox CE, Carson SS. Cost and health care utilization in ards-different from other critical illness. Semin Respir Crit Care Med. 2013;34(4):529–36.
- Bice T, Carson SS. Acute respiratory distress syndrome: cost (early and long-term). Semin Respir Crit Care Med. 2019;40(1):137–44.
- Raj R, Bendel S, Reinikainen M, Hoppu S, Laitio R, Ala-Kokko T, dkk. Costs, outcome and cost-effectiveness of neurocritical care: a multi-center observational study. Crit Care. 2018;22(1):225.
- Rochmah TN, Rahmawati IT, Dahlui M, Budiarto W, Bilqis N. Economic burden of stroke disease: a systematic review. Int J Environ Res and Public Health. 2021;18(14):7752.
- Kaier K, Heister T, Wolff J, Wolkewitz M. Mechanical ventilation and the daily cost of ICU care. BMC Health Serv Res. 2020;20(1):267.
- Keuffel EL, Stevens M, Gunnarsson C, Rizzo J, Sessler DI, Maheshwari K. A monte carlo simulation estimating US hospital cost reductions associated with hypotension control in septic ICU patients. J Med Econ. 2019;22(4):383–9.
- Srisawat N, Lawsin L, Uchino S, Bellomo R, Kellum JA. Cost of acute renal replacement therapy in the intensive care unit: results from the beginning and ending supportive therapy for the Kidney (BEST kdney) Study. Crit Care. 2010;14(2):R46.
- Mastrogianni M, Galanis P, Kaitelidou D, Konstantinou E, Fildissis G, Katsoulas T. Factors affecting adult intensive care units costs by using the bottom-up and top-down costing methodology in OECD countries: a systematic review. Intensive Crit Care Nurs. 2021;66:103080.
- Aung YN, Nur AM, Ismail A, Aljunid SM. Characteristics and outcome of high-cost ICU patients. Clinicoecon Outcomes Res. 2019;11:505–13.
- Robert R, Coudroy R, Ragot S, Lesieur O, Runge I, Souday V, dkk. Influence of ICU-bed availability on ICU admission decisions. Ann Intensive Care. 2015;5(1):55.
- Town JA, Churpek MM, Yuen TC, Huber MT, Kress JP, Edelson DP. Relationship between ICU bed availability, ICU readmission, and cardiac arrest in the general wards. In: Crit Care Med. 2014;42(9):2037–41.
DOI: https://doi.org/10.15851/jap.v12n2.3740
Article Metrics
Abstract view : 124 timesPDF - 49 times
This Journal indexed by
JAP is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
View My Stats